Company Overview and News

30
Annaly Capital And Arlington Asset Investment: MBS Pricing For First Half Of Q3 2018 (Includes Current BV Projections)

2018-08-13 seekingalpha
Following continued requests, this article analyzes fixed-rate agency MBS price movements during the third quarter of 2018 (through 8/10/2018).
NYMTO ORC FNMA CHMI NYMTP CIM AI TWO AGNC AIW MO WMC NRZ AIC CYS TRI MITT FMCKI FMCKJ FMCCO FMCCP FMCCM FMCCN MFO FMCCI DX NLY FMCCJ FMCCG FMCKO FMCKP FMCKM FMCKN FMCKK FMCKL ARR MFA FMCC IVR NYMT FMCCS FMCCT

11
How To Retire Comfortably By 62 With A Million

2018-08-12 seekingalpha
A million dollars is not the same as it used to be. Still, along with social security, it is enough for most people to retire on comfortably.
OPRF STOR MSCA STAG VTR ARCC GBDC NRZ O MAIN NLY HQH ARU MSCA.CL OHI

1
Annaly Capital Management: This 11.5%-Yielding Mortgage REIT Is Still A Buy

2018-08-09 seekingalpha
Annaly Capital Management is a compelling high-yield mortgage REIT choice for investors with a high risk tolerance.
NLY

0
Annaly (NLY) Stock Up on Q2 Earnings Beat, Lower NII Hurts

2018-08-03 zacks
Post the second-quarter earnings release on Aug 1, shares of Annaly Capital Management (NLY - Free Report) inched up 0.9% during regular trading session, likely reflecting investors’ reaction toward an earning beat negated by lower net interest income (NII) recorded at quarter end.
NLY HST OUT

0
Annaly Capital Management, Inc. 2018 Q2 - Results - Earnings Call Slides

2018-08-02 seekingalpha
The following slide deck was published by Annaly Capital Management, Inc. in conjunction with their 2018 Q2 earnings call.
NLY

2
Bimini Capital Management Remains Notably Undervalued (Potential For 1-Year 50% Upside)

2018-07-24 seekingalpha
This article first provides an analysis of BMNM’s RMBS portfolio (includes the company’s pass-through and structured securities). This analysis explains why this portfolio outperforms most fixed-rate agency mREIT companies.
AGNCB NLY ORC ARR BMNM AGNCP AGNC MO

10
A Portfolio With Few Stocks, Good Return, And Low Volatility

2018-07-19 seekingalpha
I created a new kind of portfolio in 2018 that attempted to reduce risk without the use of fixed income. My portfolio is made out of entirely common stock with a focus on REITs. With this strategy, I've been able to so far outpace the S&P 500 in 2018. But I have been able to cut down on a lot of volatility. I have chosen to try to reduce risk and volatility through diversification through low correlation between assets.
DOC NRZ NLY MSFT

10
China Cannot Derail The U.S. Economy - Cramer's Mad Money (7/18/18)

2018-07-19 seekingalpha
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Wednesday, July 18.
PEI CBJC INGR NFLX UAL ALGN NLY FRT GOOGL FHN SPG IFF

13
AGNC Investment's Q2 2018 And 7/13/2018 BV Projection (Includes NLY BV Projection)

2018-07-18 seekingalpha
I am projecting AGNC will report a minor decrease in quarterly BV for the second quarter of 2018. Most agency peers will also experience a similar type of BV decrease.
NYMTO ORC CHMI NYMTP CIM AI TWO AGNC AIW MO WMC NRZ AIC CYS MTGE MITT MFO DX NLY ARR MFA HTS IVR NYMT

0
How To Retire At 62 With A Measly Million

2018-07-16 seekingalpha
Ted and Mary build a portfolio around a mix of dividend champions and other high-yielding investments.
GBLI GBLIZ NLY

29
AGNC Investment's Q2 2018 Income Statement And Earnings Preview - Part 3 (Modest MBS Price Decreases)

2018-07-16 seekingalpha
I am projecting AGNC will report a combined modest-notable net unrealized loss on available-for-sale securities and investment securities measured at FMV for the second quarter of 2018.
NYMTO ORC FNMA CHMI NYMTP CIM AI TWO AGNC AIW MO WMC NRZ AIC CYS TRI MITT FMCKI FMCKJ FMCCO FMCCP FMCCM FMCCN MFO FMCCI DX NLY FMCCJ FMCCG FMCKO FMCKP FMCKM FMCKN FMCKK FMCKL ARR MFA FMCC HTS IVR NYMT FMCCS FMCCT

0
Is it Wise to Hold Annaly (NLY) Stock in Your Portfolio Now?

2018-07-10 zacks
Annaly Capital Management, Inc.’s (NLY - Free Report) focus on prudent selection of assets and effective allocation of capital has enabled the company to achieve better returns. However, any adverse developments in the financial market conditions may result in de-leveraging of the global financial system and forced sale of mortgage assets, widening the spreads on mortgage backed securities (MBSs).
NLY CXP PSB

13
AGNC Investment's Q2 2018 Income Statement And Earnings Preview - Part 2 (Hedges To The Rescue Once Again)

2018-07-09 seekingalpha
Fairly similar to the prior quarter, I am projecting AGNC will report a modest-notable gain regarding the company’s derivative instruments and other securities for the second quarter of 2018.
NYMTO MTGE ORC CHMI NYMTP AI TWO AGNC AIW NRZ AIC NLY CYS ARR NYMT

26
Merck Has The Best Anti-Cancer Portfolio - Cramer's Lightning Round (7/6/18)

2018-07-09 seekingalpha
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Friday, July 6.
IBM FDS CARA NLY BABA PPG MRK YRD BIDU

56
High-Yield Investment Strategy Fails

2018-07-03 seekingalpha
The performance of 59 securities, which were selected by SA contributors for their high-yield portfolios in 2014, are identified and analyzed for the period May 2014 to July 2018.
AIY AINV ARI PCI NYMTO HTF KAP OSLE NYMTP KCAP FGB AI CMO TWO SDRL HTFA AGNC AIW SLRA RSO WMC AIC AIB TCRD PSEC NMFC CYS AIF TSLF MCX SCQ XAN PBB SCA MCQ HRZN CHW OXLCO MCV OXLCN STWD.WI MITT SCM HTGZ SLRC BIT MCC TCRX ARCC GBDC CLMT MFO DX NLY TCPC TCRZ HTGX OXLC HTGY ARU OCSL EFC MFA NYMT HTGC STWD

Related Articles

BLDP: Ballard Power Systems Analysis and Research Report

2018-08-13 - Asif

Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...

MARA: Marathon Patent Group Analysis and Research Report

2018-08-13 - Asif

Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...

ECYT: Endocyte Analysis and Research Report

2018-08-13 - Asif

Business and Organization Endocyte, Inc. is a biopharmaceutical company and leader in developing targeted therapies for the treatment of cancer. The Company uses drug conjugation technology to create novel therapeutics and companion imaging agents for personalized targeted therapies. The agents actively target receptors that are over-expressed on diseased cells relative to healthy cells, such as prostate specific membrane antigen (“PSMA”) in prostate cancer. This targeted approach is designed to safely enable the delivery of highly potent drug payloads. The companion imaging agents are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment. In September 2017, the Company entered into a Development and License Agreement (the “License Agreement”) with ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH (“ABX”), pursuant to which the Company acquired exclusive ...

CUSIP: 035710508